Medicare Enrolled
Dr. Michael Tassavor, MD
MOHS-Micrographic Surgery Physician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tassavor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tassavor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tassavor
Dr. Michael Tassavor is a mohs-micrographic surgery physician in New York, NY, with 8 years of NPI registration. Based on federal Medicare data, Dr. Tassavor performed 1,520 Medicare services across 1,008 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tassavor received a total of $7,439 from 28 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tassavor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years in practice
▲ 1,520 Medicare services
$7,439 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,520
Medicare services
Bottom 33% in NY for mohs-micrographic surgery physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,008
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~190 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
366 | $4 | $28 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $59 | $214 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
139 | $36 | $144 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
122 | $67 | $248 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $32 | $105 |
| Intraoperative pathology examination, first tissue block A pathologist examines a tissue sample removed during surgery to provide a preliminary diagnosis. This test is performed on the first tissue block obtained from the procedure. |
90 | $71 | $175 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
83 | $41 | $238 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
72 | $494 | $1,610 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
64 | $53 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $108 | $385 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
42 | $497 | $1,588 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $84 | $311 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 30 | $354 | $1,177 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
25 | $1 | $24 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
20 | $33 | $144 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $132 | $500 |
| Skin graft repair, 10.1-30 sq cm A surgical procedure to repair wounds on the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin. The graft covers an area between 10.1 and 30.0 square centimeters. |
15 | $532 | $1,678 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
15 | $67 | $265 |
| Skin graft repair of eyelid, nose, ear, or lip, 10 sq cm or less A surgical procedure to repair a wound on the eyelid, nose, ear, or lip by transferring a small piece of skin. The transferred skin covers an area of 10 square centimeters or less. |
14 | $468 | $1,318 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
13 | $217 | $1,425 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
13 | $38 | $135 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
11 | $178 | $719 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
11 | $151 | $694 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,439
Total received (2021-2024)
Avg $1,860/year across 4 years
Top 23% in NY for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,439 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,414
2023
$2,130
2022
$1,597
2021
$296
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
LEO Pharma Inc.
$851
E.R. Squibb & Sons, L.L.C.
$609
PFIZER INC.
$331
Arcutis Biotherapeutics, Inc.
$324
Janssen Biotech, Inc.
$221
Dermavant Sciences, Inc.
$188
Regeneron Healthcare Solutions, Inc.
$177
ABBVIE INC.
$167
Novartis Pharmaceuticals Corporation
$96
Incyte Corporation
$87
Lilly USA, LLC
$63
Regeneron Pharmaceuticals, Inc.
$53
MAYNE PHARMA COMMERCIAL LLC
$50
UCB, Inc.
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
Amgen Inc.
$31
Organogenesis Inc.
$29
GENZYME CORPORATION
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Kyowa Kirin, Inc.
$16
Verrica Pharmaceuticals Inc.
$15
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2021-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,298
LEO Pharma Inc.
$851
ABBVIE INC.
$739
Arcutis Biotherapeutics, Inc.
$596
Janssen Biotech, Inc.
$562
PFIZER INC.
$506
Novartis Pharmaceuticals Corporation
$415
Dermavant Sciences, Inc.
$412
Incyte Corporation
$400
Lilly USA, LLC
$299
Regeneron Healthcare Solutions, Inc.
$230
AbbVie Inc.
$218
UCB, Inc.
$193
MAYNE PHARMA COMMERCIAL LLC
$156
Genentech USA, Inc.
$140
Helsinn Therapeutics (U.S.), Inc.
$125
Regeneron Pharmaceuticals, Inc.
$53
Organogenesis Inc.
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
Amgen Inc.
$31
GENZYME CORPORATION
$20
ConvaTec Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Kyowa Kirin, Inc.
$16
Sandoz Inc.
$16
Verrica Pharmaceuticals Inc.
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Biofrontera Inc.
$11
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · BOTOX · Bimzelx · CIBINQO · COSENTYX · Cimzia · DUPIXENT · EUCRISA · Erivedge · HUMIRA · ILUMYA · INNOVAMATRIX AC · JUBLIA · LIBTAYO · LITFULO · OPZELURA · Otezla · Poteligeo · Puraply · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TREMFYA · VALCHLOR · VTAMA · Winlevi · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Mohs-micrographic surgery physicians within 10 mi
39
Per 100K population
2.4
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.6 mi
0.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tassavor is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tassavor experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Tassavor performed 366 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tassavor receive payments from pharmaceutical companies?
Yes. Dr. Tassavor received a total of $7,439 from 28 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tassavor's costs compare to other mohs-micrographic surgery physicians in New York?
Dr. Tassavor's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tassavor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in New York
Browse mohs-micrographic surgery physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in NY
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in NY
Which NY mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology